Sort
16,300 grants matching “fatty liver disease”
Project 4: Innate Immunity and Cell Death in ALD
$249,638Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · P50 · FY2016 · AA
Project 4: Innate Immunity and Cell Death in ALD
$249,638Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · P50 · FY2019 · AA
Project 4: Innate Immunity and Cell Death in ALD
$249,638Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · P50 · FY2020 · AA
Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury
$249,638Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · P50 · FY2019 · AA
Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury
$249,637Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · P50 · FY2017 · AA
Project 4: Innate Immunity and Cell Death in ALD
$249,635Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · P50 · FY2017 · AA
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Clinical Center-Cleveland site
$249,613Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2025 · DK
Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure
$249,474Syed A. Hashsham · Michigan State University · P42 · FY2013 · ES
Obesity and Hepatic Steatosis
$249,406Michael J Pagliassotti · Colorado State University · R56 · FY2010 · DK
REGULATION OF LIVER FUNCTION BY MAPK/MKP-1
$249,372Anton M Bennett · Yale University · P01 · FY2009 · DK
Core 1: Biostatistics & Bioinformatics Core
$249,368Lynne R Wilkens · University Of Hawaii At Manoa · P20 · FY2023 · CA
Enhancing effectiveness of existing weight management programs for teens with severe obesity: A 6-month feasibility pilot study
$249,211Shelley Kirk · Cincinnati Childrens Hosp Med Ctr · R34 · FY2018 · DK
Clinical Research Network in Nonalcoholic Steatohepatitis
$249,189Kris Kowdley · Liver Institute Northwest Pllc · U01 · FY2025 · DK
PEROXISOME PROLIFERATOR INDUCED HEPATOCARCINOGENESIS
$249,164Northwestern University · R01 · FY2003 · CA
HUMAN P450 ENZYMES AND THEIR TOXICOLOGICAL IMPACT
$249,116California Toxicology Research Institute · R01 · FY2003 · AA
Using pre-clinical biomarkers and epidemiological models to assess the effects of cannabinoids on disease
$249,000Omayma O Alshaarawy · Michigan State University · R00 · FY2018 · AT
Systems Genetics Analysis of Gene-by-Environment Interactions in Obesity
$249,000Brian Wesley Parks · University Of Wisconsin-Madison · R00 · FY2017 · HL
Genomic Regulation and Translational Potential of a Novel Smooth Muscle Cell-Derived Cell Type in Atherosclerosis
$249,000Huize Pan · Vanderbilt University Medical Center · R00 · FY2025 · HL
Synergy of lipolysis and lipophagy in alcoholic liver disease
$249,000Micah Schott · University Of Nebraska Medical Center · R00 · FY2022 · AA
Synergy of lipolysis and lipophagy in alcoholic liver disease
$249,000Micah Schott · University Of Nebraska Medical Center · R00 · FY2023 · AA
Role of FoxO1 in Lipid Metabolism
$249,000Rebecca Anne Haeusler · Columbia University Health Sciences · R00 · FY2015 · HL
Cellular and molecular mechanisms of diabetic atherosclerosis
$249,000Leigh Goedeke · Icahn School Of Medicine At Mount Sinai · R00 · FY2022 · HL
Mechanistic characterization of the anti-inflammatory function of thermogenic fat for the treatment of metabolic disorders
$249,000Evanna Louisa Mills · Dana-Farber Cancer Inst · R00 · FY2023 · DK
Genomic Regulation and Translational Potential of a Novel Smooth Muscle Cell-Derived Cell Type in Atherosclerosis
$249,000Huize Pan · Vanderbilt University Medical Center · R00 · FY2024 · HL
Adiponectin Receptors and S1P Signaling in Beta Cell Survival and Proliferation
$249,000William L Holland · Ut Southwestern Medical Center · R00 · FY2014 · DK